Results 31 to 40 of about 3,290,621 (312)

Dermatomyositis and Malignancy

open access: yesJournal of Investigative Dermatology, 1993
During the past 12 years, many studies applying strict diagnostic criteria have been published that have attempted to settle the controversy about the reality of the association between dermatomyositis and malignancy. Although retrospective, recent studies have shown an increased incidence of malignancy among patients with dermatomyositis when compared
Bernard, Philippe   +1 more
openaire   +2 more sources

‘I am not someone who gets skin cancer’: Risk, time and malignant melanoma [PDF]

open access: yes, 2013
‘Delay’ is a term used in the cancer literature since the 1930s to describe the period between self-detection of a concerning sign of possible disease and presentation to a health professional.
Heyman, Bob   +5 more
core   +1 more source

Author Correction to: Single-cell RNA-seq reveals a concomitant delay in differentiation and cell cycle of aged hematopoietic stem cells

open access: yesBMC Biology, 2021
An amendment to this paper has been published and can be accessed via the original article.
Léonard Hérault   +5 more
doaj   +1 more source

Malignant Craniopharyngioma

open access: yesArchives of Pathology & Laboratory Medicine, 1999
Abstract Craniopharyngiomas are histologically and cytologically benign epithelial tumors of the central nervous system that may be locally aggressive and tend to recur after excision. Malignant change in craniopharyngiomas is extremely rare; we found only 4 such reports in the literature.
T, Kristopaitis   +3 more
openaire   +2 more sources

Reducing inequalities in care for patients with non-malignant diseases: Insights from a realist evaluation of an integrated palliative care pathway [PDF]

open access: yes, 2016
Background: The need for palliative care is growing internationally with an increasing prevalence of non-malignant diseases. The integrated care pathway was implemented in primary care by multidisciplinary teams from 2009 in a locality in the North East
Lhussier, Monique   +4 more
core   +1 more source

Immunoreactive human chorionic gonadotropin and its free ß-subunit in serum and ascites of patients with malignant tumors [PDF]

open access: yes, 1992
Human chorionic gonadotropin (hCG) is a clinically relevant marker of trophoblastic and nontrophoblastic malignancies. In the present studies, in addition to determining serum hCG, we investigated the presence and properties of hCG immunoreactivity in ...
Mann, Klaus   +4 more
core   +1 more source

Plasmablastic Richter Transformation of Chronic Lymphocytic Leukemia With Aberrant Epithelial Marker Expression Presenting as a Pleural Effusion: A Diagnostic Challenge

open access: yesCase Reports in Pathology
Richter transformation (RT) is a well-known complication of chronic lymphocytic leukemia (CLL), and it is usually characterized by high-grade transformation to diffuse large B-cell lymphoma or, less commonly, to classic Hodgkin lymphoma.
Jamie Rogers   +8 more
doaj   +1 more source

Single-cell RNA-seq reveals a concomitant delay in differentiation and cell cycle of aged hematopoietic stem cells

open access: yesBMC Biology, 2021
Background Hematopoietic stem cells (HSCs) are the guarantor of the proper functioning of hematopoiesis due to their incredible diversity of potential.
Léonard Hérault   +5 more
doaj   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014–2024)

open access: yesAnnals of Hematology
Acute myeloid leukemia (AML) is a biologically heterogeneous hematologic malignancy, and racial disparities in outcomes remain incompletely characterized.
Utsav Joshi   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy